Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Immunomodulatory Effect of a New Herbal Preparation (HemoHIM) in Cyclophosphamide-treated Mice

  • Park, Hae-Ran (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI)) ;
  • Jo, Sung-Kee (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI)) ;
  • Jung, U-Hee (Radiation Biotechnology Research Team, Advanced Radiation Technology Institute, Jeongeup Campus of Korea Atomic Energy Research Institute (KAERI)) ;
  • Kim, Sung-Ho (College of Veterinary Medicine, Chonnam National University) ;
  • Yee, Sung-Tae (Department of Biology, Sunchon National University)
  • Published : 2006.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The immunomodulatory effect of a new herbal preparation, HemoHIM, on the recovery from leukopenia induced by cyclophosphamide treatment was investigated. The HemoHIM was made up with an addition of the ethanol-insoluble fraction to the total water extract of Angelica Radix, Cnidii Rhizoma and Paeonia Radix. Daily oral administration of 100 mg/kg BW or 500 mg/kg BW HemoHIM accelerated the recovery from cyclophosphamide-induced leukopenia. HemoHIM increased the number of leukocytes and lymphocytes in the peripheral blood when compared with the cyclophosphamide-treated control. Moreover, the suppressed natural killer (NK) cell activity and interferon $(IFN)-{\gamma}$ secretion in the cyclophosphamide-treated mice were restored by the administration of HemoHIM. HemoHIM significantly reduced the abnormally heightened ratio of interleukin $(IL)-4/IFN-{\gamma}$ and immunoglobulin (Ig)E/IgG2a in the cyclophosphamide-treated mice. These results suggest that HemoHIM accelerates the recovery from leukopenia and alleviates the imbalanced T helper (Th)l/Th2 responses in the cyclophosphamide-treated mice. Additionally, HemoHIM was found to stimulate normal splenocytes to secrete not only Thl type cytokines such as $IFN-{\gamma}$ and IL-2, but also Th2 type cytokine IL-4. In conclusion, our results show that HemoHIM certainly has an influence on the balanced recovery of immune cells and the activation of their activities in the cyclophosphamide-treated mice.

Keywords

References

  1. Kaneko M, Kawakita T, Kumazawa Y, Takimoto H, Nomoto K, Yoshikawa T. 1999. Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacology 44: 223-231 https://doi.org/10.1016/S0162-3109(99)00050-8
  2. Chu DT, Wong WL, Mavligit GM. 1988. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophos-phamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 25: 125-129
  3. Jin R, Wan LL, Mitsuishi T, Sato S, Akuzawa Y, Kodama K, Kurashige S. 1994. Effect of shi-ka-ron and Chinese herbs on cytokine production of macrophage in immunocompromised mice. Am J Chin Med 22: 255-266 https://doi.org/10.1142/S0192415X94000310
  4. Xu X, Malave A. 2001. Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats. Pharmacol Toxicol 88: 232-237 https://doi.org/10.1034/j.1600-0773.2001.d01-109.x
  5. Allison AC. 2000. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 47: 63-83 https://doi.org/10.1016/S0162-3109(00)00186-7
  6. Brinkman CJ, Nillesen WM, Hommes OR. 1984. The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis. Acta Neurol Scand 69: 90-96 https://doi.org/10.1111/j.1600-0404.1984.tb07784.x
  7. Moody DJ, Fahey JL, Grable E, Ellison GW, Myers LW. 1987. Administration of monthly pulses of cyclophos-phamide in multiple sclerosis patients. Delayed recovery of several immune parameters following discontinuation of long-term cyclophosphamide treatment. J Neuroimmunol 13: 175-182 https://doi.org/10.1016/0165-5728(86)90063-9
  8. Sasaki G, Satoh T, Yokozeki H, Katayama I, Nishioka K. 2000. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: Functional roles of inter-leukin-5-producing $CD4^+$ lymphocytes. Cellular Immunol 203: 124-133 https://doi.org/10.1006/cimm.2000.1677
  9. Smith DR, Balashov KE, Hafler DA, Khoury SJ, Weiner HL. 1997. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosino-philia. Ann Neurol 42: 313-318 https://doi.org/10.1002/ana.410420307
  10. Takashima H, Smith DR, Fukaura H, Khoury SJ, Hafler DA, Weiner HL. 1998. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Clin Immunol Immunopathol 88: 28-34 https://doi.org/10.1006/clin.1998.4558
  11. Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khoury SJ. 1998. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 102: 671-678 https://doi.org/10.1172/JCI3125
  12. Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL. 2004. Cyclophosphamide modulates $CD4^+$ T cells into a T helper type 2 phenotype and reverses increased IFN-${\gamma}$production of $CD8^+$ T cells in secondary progressive multiple sclerosis. J Neuroimmunol 146: 189-198 https://doi.org/10.1016/j.jneuroim.2003.10.036
  13. Weiner HL, Cohen JA. 2002. Treatment of multiple sclerosis with cyclophosphamide: critical review of clin-ical and immunologic effects. Mult Scler 8: 142-15 https://doi.org/10.1191/1352458502ms790oa
  14. Romagnani S. 1997. The Th1/Th2 paradigm. Immunol Today 18: 263-266
  15. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787-793 https://doi.org/10.1038/383787a0
  16. Park HR, Kim SH, Yee ST, Byun MW, Jo SK. 2005. Effect of a herb mixture (HIM-I) on the protection of the hematopoietic-immune system and self-renewal tissues against radiation damage. J Korean Soc Food Sci Nutr 34: 605-612 https://doi.org/10.3746/jkfn.2005.34.5.605
  17. Jo SK, Park HR, Jung UH, Oh H, Kim SH, Yee ST. 2005. Protective effect of a herbal preparation (HemoHIM) on the self-renewal tissues and immune system against ${\gamma}$- irradiation. J Korean Soc Food Sci Nutr 34: 805-813 https://doi.org/10.3746/jkfn.2005.34.6.805
  18. Kajioka EH, Andres ML, Li J, Mao XW, Moyers MF, Nelson GA, Slater JM, Gridley DS. 2000. Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat Res 153: 587-594 https://doi.org/10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2
  19. Coffman RL, Catry J. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-${\gamma}$. J Immunol 136: 949-954
  20. Snapper CM, Paul WE. 1987. Interferon-${\gamma}$ and B cell stimulatory-factor-I reciprocally regulate Ig isotype pro-duction. Science 236: 944-947 https://doi.org/10.1126/science.3107127
  21. Paul WE, Seder RA, Plaut M. 1993. Lymphokine and cytokine production by Fc${\varepsilon}$RI cells. Adv Immunol 53: 1-29 https://doi.org/10.1016/S0065-2776(08)60496-4
  22. Nadler MJ, Matthews SA, Turner H, Kinet JP. 2000. Signal transduction by the high affinity immunoglobulin E receptor Fc${\varepsilon}$RI: coupling form to function. Adv Immunol 76: 325-35 https://doi.org/10.1016/S0065-2776(01)76022-1
  23. O'Garra A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283 https://doi.org/10.1016/S1074-7613(00)80533-6
  24. Constant SL, Bottomly K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Ann Rev Immunol 15: 297-322 https://doi.org/10.1146/annurev.immunol.15.1.297
  25. Mosmann TR, Coffman RL. 1998. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145-171 https://doi.org/10.1146/annurev.iy.07.040189.001045

Cited by

  1. Restoration of the immune functions in aged mice by supplementation with a new herbal composition, HemoHIM vol.22, pp.1, 2008, https://doi.org/10.1002/ptr.2255
  2. Antiinflammatory activity of an herbal preparation (HemoHIM) in rats vol.21, pp.7, 2007, https://doi.org/10.1002/ptr.2068
  3. HemoHIM Enhances the Therapeutic Efficacy of Ionizing Radiation Treatment in Tumor-Bearing Mice vol.13, pp.1, 2010, https://doi.org/10.1089/jmf.2009.1049
  4. Herbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4 vol.16, pp.1, 2016, https://doi.org/10.1186/s12906-016-1045-9
  5. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice vol.9, pp.1, 2009, https://doi.org/10.1186/1471-2407-9-85
  6. Cyclophosphamide로 유발된 면역억제 마우스에서 생강의 면역 억제 효과 vol.32, pp.1, 2006, https://doi.org/10.17555/ksvc.2015.02.32.1.56
  7. Standardized Extract (HemoHIM) Protects against Scopolamine-Induced Amnesia in a Murine Model vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/8884243